Effect of informed consent on patient characteristics in a stroke thrombolysis trial - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Neurology Année : 2017

Effect of informed consent on patient characteristics in a stroke thrombolysis trial

Götz Thomalla
  • Fonction : Auteur
Florent Boutitie
  • Fonction : Auteur
Jochen Fiebach
  • Fonction : Auteur
Claus Simonsen
  • Fonction : Auteur
Norbert Nighoghossian
Salvador Pedraza
  • Fonction : Auteur
Robin Lemmens
  • Fonction : Auteur
Keith Muir
  • Fonction : Auteur
Christoph Heesen
  • Fonction : Auteur
Martin Ebinger
  • Fonction : Auteur
Ian Ford
  • Fonction : Auteur
Bastian Cheng
  • Fonction : Auteur
Tae-Hee Cho
  • Fonction : Auteur
  • PersonId : 918240
Josep Puig
  • Fonction : Auteur
Vincent Thijs
  • Fonction : Auteur
Matthias Endres
  • Fonction : Auteur
Jens Fiehler
  • Fonction : Auteur
Christian Gerloff
  • Fonction : Auteur

Résumé

Objective: To determine whether the manner of consent, i.e., informed consent by patients themselves or informed consent by proxy, affects clinical characteristics of samples of acute stroke patients enrolled in clinical trials. Methods: We analyzed the manner of obtaining informed consent in the first 1,005 patients from WAKE-UP, an investigator-initiated, randomized, placebo-controlled trial of MRI-based thrombolysis in stroke patients with unknown time of symptom onset running in 6 European countries. Patients providing informed consent by themselves were compared with patients enrolled by proxy consent. Baseline clinical measures were compared between groups. Results: In 359 (35.7%) patients, informed consent was by proxy. Patients with proxy consent were older (median 71 vs 66 years, p < 0.0001) and had a higher frequency of arterial hypertension (58.2% vs 43.4%, p < 0.0001). They showed higher scores on the NIH Stroke Scale (median 11 vs 5, p < 0.0001) and more frequently aphasia (73.7% vs 20.0%, p < 0.0001). The rate of proxy consent varied among countries ( p < 0.0001), ranging from 77.1% in Spain to 1.2% in Denmark. Conclusions: Patients recruited by proxy consent were older, had more severe strokes, and had higher prevalence of aphasia than those with capacity to give personal consent. Variations in the manner of consent across countries may influence trial results. Clinicaltrials.gov and Clinicaltrialsregister.eu identifiers: NCT01525290 ( clinicaltrials.gov ); 2011-005906-32 ( clinicaltrialsregister.eu ).

Dates et versions

hal-04152536 , version 1 (05-07-2023)

Identifiants

Citer

Götz Thomalla, Florent Boutitie, Jochen Fiebach, Claus Simonsen, Norbert Nighoghossian, et al.. Effect of informed consent on patient characteristics in a stroke thrombolysis trial. Neurology, 2017, 89 (13), pp.1400-1407. ⟨10.1212/WNL.0000000000004414⟩. ⟨hal-04152536⟩

Collections

HCL
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More